Ömer UYSAL, Eren GÖZKE, Necati ÇAKIR, Hülya AZAKLI, Duran ÜSTEK

MEFV mutation frequencies in a Turkish cohort with low prevalence of familial Mediterranean fever

Background/aim: Familial Mediterranean fever (FMF) is a genetically recessive autoinflammatory disease caused by mutations in the Mediterranean fever (MEFV) gene. The aim of this study was to investigate the frequencies of the most common MEFV mutations among a sample of healthy individuals from the Havsa population of European Turkey, where FMF is less prevalent compared to Asian Turkey. Materials and methods: The study group consisted of 263 unrelated healthy adults. All of the participants were analyzed for the M694V, V726A, M680I, and E148Q mutations in the MEFV gene. Results: In total, 25 of the 263 individuals carried MEFV mutations (9.5%). The observed allele frequencies were 1.5% for M694V (95% confidence interval [CI] 0.5-2.5), 2.6% for E148Q (95% CI 1.6-3.9), 0.5% for M680I (95% CI 0.0-1.1), and 0.0% for V726A. The frequencies of the M694V, M680I, and E148Q mutations were not significantly different from allele frequencies (approximately 20%) determined for other regions of Turkey where FMF is more prevalent. Conclusion: These data suggest that the positivity of the MEFV gene mutation tests have lower predictive value in a population with low FMF prevalence.Key words: Familial Mediterranean fever, mutations, MEFV gene

PDF

___

1. Heller H, Sohar E, Sherf L. Familial Mediterranean fever. Archives of Internal Medicine 1958; 102: 50-71. doi: 10.1001/ archinte.1958.00260190052007
2. Touitou I. The spectrum of familial Mediterranean fever (FMF) mutations. European Journal of Human Genetics 2001; 9: 477- 483. doi: 10.1038/sj.ejhg.5200658
3. French FMF Consortium. A candidate gene for familial Mediterranean fever. Nature Genetics 1997; 17: 25-31. doi: 10.1038/ng0997-25
4. The International FMF Consortium. Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell 1997; 90: 797-807. doi: 10.1016/s0092-8674(00)80539-5
5. Touitou I, Sarkisian T, Medlej-Hashim M, Tunca M, Livneh A et al. International study group for phenotype-genotype correlation in familial Mediterranean fever. Country as the primary risk factor for renal amyloidosis in familial Mediterranean fever. Arthritis and Rheumatism 2007; 56: 1706-1712. doi: 10.1002/art.22507
6. Tunca M, Akar S, Onen F, Ozdogan H, Kasapcopur O et al. Familial Mediterranean Fever (FMF) in Turkey. Results of a nationwide multicenter study. Medicine 2005; 84: 1-11. doi: 10.1097/01.md.0000152370.84628.0c
7. Bilge SY, Sarı I, Solmaz D, Şenel S, Emmungil H et al. The distribution of MEFV mutations in Turkish FMF patients: multicenter study representing results of Anatolia. Turkish Journal of Medical Sciences 2019; 49 (2): 472-477. doi: 10.3906/ sag-1809-100
8. Çakır N, Pamuk ON, Derviş E, İmeryüz N, Uslu H et al. The prevalences of some rheumatic diseases in western Turkey: Havsa study. Rheumatology International 2012; 32: 895-908. doi: 10.1007/s00296-010-1699-4
9. Yigit S, Bagci H, Ozkaya O, Ozdamar K, Cengiz K et al. MEFV mutations in patients with familial Mediterranean fever in the Black Sea region of Turkey. The Journal of Rheumatology 2008; 35: 106-113.
10. Tunca M, Akar S, Hawkins PN, Booth SE, Şengül B et al. The significance of paired MEFV mutations in individuals without symptoms of familial Mediterranean fever. European Journal of Human Genetics 2002; 10: 786-789. doi: 10.1038/ sj.ejhg.5200900
11. Cosan F, Üstek D, Oku B, Duymaz-Tozkir J, Cakiris A et al. Association of familial Mediterranean fever – related MEFV variations with ankylosing spondylitis. Arthritis and Rheumatism 2010; 62: 3232-3236. doi: 10.1002/art.27683
12. Yilmaz E, Ozen S, Balci B, Duzova A, Topaloglu R et al. Mutation frequency of familial Mediterranean fever and evidence for a high carrier rate in the Turkish population. European Journal of Human Genetics; 9: 553-555. doi: 10.1038/sj.ejhg.5200674
13. Imirzalioglu M, Dursun A, Tastan B, Soysal Y, Yakicier MC. MEFV gene is a probable susceptibility gene for Behçet’s disease. Scandinavian Journal of Rheumatology 2005; 34: 55- 58. doi: 10.1080/03009740510017931
14. Akin H, Onay H, Turker E, Cogulu O, Ozkinay F. MEFV Mutations in patients with familial Mediterranean fever from the Aegean region of Turkey. Molecular Biology Reports 2010; 37: 93-98. doi: 10.1007/s11033-009-9543-1
15. Yilmaz G, Senes M, Kayalp D, Yucel D. Is Turkish MEFV mutations spectrum different among regions? Journal of Clinical Laboratory Analysis. 2016; 30 (5): 641-644. doi: 10.1002/jcla.21915
16. Giaglis S, Papadopoulos V, Kambas K, Doumas M, Tsironidou V et al. MEFV alterations and populations genetics analysis in a large cohort of Greek patients with familial Mediterranean fever. Clinical Genetics 2007; 71: 458-467. doi: 10.1111/j.1399- 0004.2007.00789.x
17. Atagunduz P, Ergun T, Direskeneli H. MEFV mutations are increased in Beçhet’s disease (BD) and are associated with vascular involvement. Clinical and Experimental Rheumatology 2003; 21: 35-37
18. Touitou I, Magne X, Molinari N, Navarro A, Quellec AL et al. MEFV mutations in Behçet’s disease. Human Mutation 2000; 16: 271-272. doi: 10.1002/1098-1004(200009)16:3<271::AIDHUMU16>3.0.CO;2-A
19. Papadopoulos V, Mitroulis I, Giaglis S. MEFV heterogeneity in Turkish familial Mediterranean fever patients. Molecular Biology Reports 2010; 37: 355-358. doi: 10.1007/s11033-009- 9779-9